|
Volumn 162, Issue 5-6, 2007, Pages 331-338
|
Glioblastomas are resistant to apoptosis but less resistant to the autophagic process;Les glioblastomes sont résistants a l'apoptose mais de façon moindre au processus d'autophagie.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKYLATING AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
DACARBAZINE;
DRUG DERIVATIVE;
RAPAMYCIN;
TEMOZOLOMIDE;
TRANSCRIPTION FACTOR;
ALGORITHM;
APOPTOSIS;
ARTICLE;
AUTOPHAGY;
BRAIN TUMOR;
CELL MOTION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DRUG EFFECT;
FORECASTING;
GLIOBLASTOMA;
HUMAN;
PATHOLOGY;
PROGNOSIS;
ALGORITHMS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, ALKYLATING;
APOPTOSIS;
AUTOPHAGY;
BRAIN NEOPLASMS;
CELL MOVEMENT;
CLINICAL TRIALS AS TOPIC;
DACARBAZINE;
FORECASTING;
GLIOBLASTOMA;
HUMANS;
PROGNOSIS;
SIROLIMUS;
TRANSCRIPTION FACTORS;
|
EID: 44649166307
PISSN: 03778231
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|